San Diego, CA -- (SBWire) -- 06/09/2016 --An investigation on behalf of current long-term investors in shares of Transgenomic Inc (NASDAQ:TBIO) was announced over potential breaches of fiduciary duties.
Investors who purchased shares of Transgenomic Inc (NASDAQ:TBIO) and currently hold any of those NASDAQ:TBIO shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Transgenomic officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
Transgenomic Inc reported that its annual Total Revenue declined from $27.54 million in 2013 to $1.24 million in 2014, respectively $1.65 million in 2015. Shares of Transgenomic Inc (NASDAQ:TBIO) declined from $4.00 per share in early 2014 to as low as $0.48 per share on May 13, 2016.
On June 7, 2016, NASDAQ:TBIO shares closed at $0.67 per share.
Those who purchased shares of Transgenomic Inc have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
Investigation of Transgenomic Inc (NASDAQ:TBIO) for Investors Announced
An investigation on behalf of investors in Transgenomic Inc (NASDAQ:TBIO) shares over potential wrongdoing at Transgenomic was announced and NASDAQ:TBIO stockholders should contact the Shareholders Foundation.